Cargando…

Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer

BACKGROUND: Dysregulated long non-coding RNAs (lncRNAs) may serve as potential biomarkers of cancers including breast cancer (BRCA). This study aimed to identify lncRNAs with strong prognostic value for BRCA. METHODS: LncRNA expression profiles of 929 tissue samples were downloaded from TANRIC datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaozong, Song, Baorong, Zhu, Leilei, Zhang, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858983/
https://www.ncbi.nlm.nih.gov/pubmed/31741788
http://dx.doi.org/10.7717/peerj.7976
_version_ 1783471054425948160
author Wang, Yaozong
Song, Baorong
Zhu, Leilei
Zhang, Xia
author_facet Wang, Yaozong
Song, Baorong
Zhu, Leilei
Zhang, Xia
author_sort Wang, Yaozong
collection PubMed
description BACKGROUND: Dysregulated long non-coding RNAs (lncRNAs) may serve as potential biomarkers of cancers including breast cancer (BRCA). This study aimed to identify lncRNAs with strong prognostic value for BRCA. METHODS: LncRNA expression profiles of 929 tissue samples were downloaded from TANRIC database. We performed differential expression analysis between paired BRCA and adjacent normal tissues. Survival analysis was used to identify lncRNAs with prognostic value. Univariate and multivariate Cox regression analyses were performed to confirm the independent prognostic value of potential lncRNAs. Dysregulated signaling pathways associated with lncRNA expression were evaluated using gene set enrichment analysis. RESULTS: We found that a total of 398 lncRNAs were significantly differentially expressed between BRCA and adjacent normal tissues (adjusted P value <= 0.0001 and |logFC| >= 1). Additionally, 381 potential lncRNAs were correlated Overall Survival (OS) (P value < 0.05). A total of 48 lncRNAs remained when differentially expressed lncRNAs overlapped with lncRNAs that had prognostic value. Among the 48 lncRNAs, one lncRNA (LINC01614) had stronger prognostic value and was highly expressed in BRCA tissues. LINC01614 expression was validated as an independent prognostic factor using univariate and multivariate analyses. Higher LINC01614 expression was observed in several molecular subgroups including estrogen receptors+, progesterone receptors+ and human epidermal growth factor receptor 2 (HER2)+ subgroup, respectively. Also, BRCA carrying one of four gene mutations had higher expression of LINC01614 including AOAH, CIT, HER2 and ODZ1. Higher expression of LINC01614 was positively correlated with several gene sets including TGF-β1 response, CDH1 signals and cell adhesion pathways. CONCLUSIONS: A novel lncRNA LINC01614 was identified as a potential biomarker for prognosis prediction of BRCA. This study emphasized the importance of LINC01614 and further research should be focused on it.
format Online
Article
Text
id pubmed-6858983
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-68589832019-11-18 Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer Wang, Yaozong Song, Baorong Zhu, Leilei Zhang, Xia PeerJ Molecular Biology BACKGROUND: Dysregulated long non-coding RNAs (lncRNAs) may serve as potential biomarkers of cancers including breast cancer (BRCA). This study aimed to identify lncRNAs with strong prognostic value for BRCA. METHODS: LncRNA expression profiles of 929 tissue samples were downloaded from TANRIC database. We performed differential expression analysis between paired BRCA and adjacent normal tissues. Survival analysis was used to identify lncRNAs with prognostic value. Univariate and multivariate Cox regression analyses were performed to confirm the independent prognostic value of potential lncRNAs. Dysregulated signaling pathways associated with lncRNA expression were evaluated using gene set enrichment analysis. RESULTS: We found that a total of 398 lncRNAs were significantly differentially expressed between BRCA and adjacent normal tissues (adjusted P value <= 0.0001 and |logFC| >= 1). Additionally, 381 potential lncRNAs were correlated Overall Survival (OS) (P value < 0.05). A total of 48 lncRNAs remained when differentially expressed lncRNAs overlapped with lncRNAs that had prognostic value. Among the 48 lncRNAs, one lncRNA (LINC01614) had stronger prognostic value and was highly expressed in BRCA tissues. LINC01614 expression was validated as an independent prognostic factor using univariate and multivariate analyses. Higher LINC01614 expression was observed in several molecular subgroups including estrogen receptors+, progesterone receptors+ and human epidermal growth factor receptor 2 (HER2)+ subgroup, respectively. Also, BRCA carrying one of four gene mutations had higher expression of LINC01614 including AOAH, CIT, HER2 and ODZ1. Higher expression of LINC01614 was positively correlated with several gene sets including TGF-β1 response, CDH1 signals and cell adhesion pathways. CONCLUSIONS: A novel lncRNA LINC01614 was identified as a potential biomarker for prognosis prediction of BRCA. This study emphasized the importance of LINC01614 and further research should be focused on it. PeerJ Inc. 2019-11-14 /pmc/articles/PMC6858983/ /pubmed/31741788 http://dx.doi.org/10.7717/peerj.7976 Text en © 2019 Wang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Molecular Biology
Wang, Yaozong
Song, Baorong
Zhu, Leilei
Zhang, Xia
Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
title Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
title_full Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
title_fullStr Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
title_full_unstemmed Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
title_short Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
title_sort long non-coding rna, linc01614 as a potential biomarker for prognostic prediction in breast cancer
topic Molecular Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858983/
https://www.ncbi.nlm.nih.gov/pubmed/31741788
http://dx.doi.org/10.7717/peerj.7976
work_keys_str_mv AT wangyaozong longnoncodingrnalinc01614asapotentialbiomarkerforprognosticpredictioninbreastcancer
AT songbaorong longnoncodingrnalinc01614asapotentialbiomarkerforprognosticpredictioninbreastcancer
AT zhuleilei longnoncodingrnalinc01614asapotentialbiomarkerforprognosticpredictioninbreastcancer
AT zhangxia longnoncodingrnalinc01614asapotentialbiomarkerforprognosticpredictioninbreastcancer